免疫系统
2019年冠状病毒病(COVID-19)
佐剂
大流行
医学
疾病
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
冠状病毒
经济短缺
免疫学
重症监护医学
感染控制
维生素D与神经学
维生素C
传染病(医学专业)
内科学
哲学
政府(语言学)
语言学
作者
Myia Aiges,Kota V. Ramana
标识
DOI:10.2174/1389557523666230324081713
摘要
Coronavirus disease-19 (COVID-19), a serious pandemic due to the SARS-CoV-2 virus infection, caused significant lockdowns, healthcare shortages, and deaths worldwide. The infection leads to an uncontrolled systemic inflammatory response causing severe respiratory distress and multiple-organ failure. Quick development of several vaccines efficiently controlled the spread of COVID-19. However, the rise of various new subvariants of COVID-19 demonstrated some concerns over the efficacy of existing vaccines. Currently, better vaccines to control these variants are still under development as several new subvariants of COVID-19, such as omicron BA-4, BA-5, and BF-7 are still impacting the world. Few antiviral treatments have been shown to control COVID-19 symptoms. Further, control of COVID-19 symptoms has been explored with many natural and synthetic adjuvant compounds in hopes of treating the deadly and contagious disease. Vitamins have been shown to modulate the immune system, function as antioxidants, and reduce the inflammatory response. Recent studies have investigated the potential role of vitamins, specifically vitamins A, B, C, D, and E, in reducing the immune and inflammatory responses and severity of the complication. In this brief article, we discussed our current understanding of the role of vitamins in controlling COVID-19 symptoms and their potential use as adjuvant therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI